Vigilance pays bigfoot - thanks
Malaysia is shown by World Bank as having a population in 2011 of 28,860,000 (rounded) - another country, another 30 million or so. Is the Malaysia announcement related to marketing progress by Gro-International? If it were, I suspect their name would also appear in the PR.
It has to be pricing or people - there is just no way any smart retailer plays 'wait and see' today. Are you kidding? The drug store wars continue and retailers globally have to fight for every dollar. Either the marketing is ineffective, or the pricing is off. BIEL made a major shift in pricing a couple of years ago, does it need another look? Is this a combination of Founder's Syndrome plus pricing plus marketing people and not being on the NASDAQ OTC:BB? The answer is to be found in one or more or all of these areas IMO. And, if I'm anywhere close to being right, then the source of the issues is management or money, or both. I understand this company has survived so far on a shoestring, but 'Founder's Syndrome' if it is a part of this dilemma is often hard to deal with, but I have thrown this balloon into the air a few times, often enough for the CEO to be taking a long and introspective look at things. Often, the "Founder's Syndrome' solution is to kick the CEO upstairs, to Chair only, and get a hotshot CEO on board with a good piece of the upside. Results count!
With the patented product line, including ALLAY which could help tens of millions of women with severe menstrual pains, no negative side-effects, ever, and all the "BIEL facts" I posted again recently, on products, the understaffing at the USFDA, etc., etc., I agree with fellow-poster, this should be 20 cents or north of it. I remain confused.
